Molecular Targets Beyond the Big 3.
Sign Up to like & getrecommendations! Published in 2020 at "Thoracic surgery clinics"
DOI: 10.1016/j.thorsurg.2020.01.004
Abstract: Lung cancer is a heterogeneous genomic disease. Smoking remains the primary cause. Genetic susceptibility and environmental exposures are responsible for 10% to 15% of cases. Targeted therapies improve survival in patients with tumors with oncogenic… read more here.
Keywords: targets beyond; beyond big; molecular targets; lung cancer ... See more keywords
Expanding Horizons in Cholangiocarcinoma: Emerging Targets Beyond FGFR2 and IDH1
Sign Up to like & getrecommendations! Published in 2025 at "International Journal of Molecular Sciences"
DOI: 10.3390/ijms262110755
Abstract: Cholangiocarcinoma (CCA) is a biliary tract cancer that accounts for approximately 3% of all gastrointestinal cancers. CCA is a “silent” disease that remains undetected for a long period of time, often presenting at an advanced… read more here.
Keywords: cholangiocarcinoma emerging; targeted therapies; expanding horizons; horizons cholangiocarcinoma ... See more keywords